A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Charde, Manoj S.
- Evaluation of Wound Healing, Anti-Inflammatory and Antioxidant Activity of Rhizomes of Curcuma longa
Authors
1 J. L. Chaturvedi College of Pharmacy, Electronic Zone Building, MIDC, Hingna Road, Nagpur-440016, Maharashtra, IN
2 Kamla Nehru College of Pharmacy, Wardha Road, Buttibori, Nagpur, MS, IN
3 Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur-440033, MS, IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 2, No 1 (2010), Pagination: 42-47Abstract
The present study deals with evaluation of antioxidant, wound healing and anti-inflammatory activity of ethanolic extract of Curcuma longa Linn. rhizomes. The ethanolic extract prepared by maceration technique was subjected to screen for antioxidant activity using DPPH radical scavenging method and wound healing activity using incision, excision, histopathological and dead space wound model and the study was supported with evaluation of granuloma tissue to estimate hydroxyproline content and histopathological evaluation. The anti-inflammatory study was carried out by using carageenan induced rat paw odema method. The tested extract of different dilutions in range 200 μg/ml to 1000 μg/ml shows activity in range of 9.34% to 18.55%. Significant increase in wound closure rate, skin breaking strength, granuloma breaking strength was observed. The hydroxyproline content was also increased with decrease in scar area. The initial healing action might be due to increased collagen deposition and better alignment, with the obtained results it can be concluded that Curcuma longa extract has significant wound healing activity and initial healing may be due to presence of curcuminoids and antimicrobial agents. The extract shows prominent anti-inflammatory activity as compared to that of standard (Ibuprofen gel). The extract shows good anti-inflammatory activity on carageenan induced rat paw odema method.Keywords
Antioxidant, Wound Healing, Anti-Inflammatory, Curcuma longa.
References
- Kailong Yuan, Qianfeng Weng, Hongying Zhang, Jianhui Xiong, Guowang Xu Application of capillary zone electrophoresis in the separation and determination of the curcuminoids in urine. Journal of Pharmaceutical and Biomedical Analysis 38 (2005) 133-138.
- P.T. Ammon, M.A. Wahl, Planta Med. 57 (1991) 1-7.
- K.K. Soudamini, R. Kuttan, J. Ethno Pharmacol. 27 (1989) 227-233.
- Masuda, A. Jitoe, Phytochemistry 32 (1993) 1557-1560.
- R. Motterlini, R. Foresti, R. Bassi, C.J. Gree, Free. Radic. Biol. Med. 15 (2000) 1303-1312.
- Koide, T., Nose, M., Ogihara, Y., Yabu, Y. and Ohta, N. (2002) Biol. Pharm. Bull. 25, 131-133.
- Nanji, A.A., Jokelainen, K., Tipoe, G.L., Rahemtulla, A., Thomas, P. and Dannenberg, A.J. (2003) Am. J. Physiol. Gastrointest. Liver Physiol. 284, G321-327.
- Frautschy, S.A., Hu, W., Kim, P., Miller, S.A., Chu, T., Harris-White, M.E. and Cole, G.M. (2001) Neurobiol. Aging 22, 993-1005.
- Janssen, Th. Gole, Chromatographia 18 (1984) 546-549.
- M. Sanagi, U.K. Ahmad, R.M. Smith, J. Chromatogr. Sci. 31 (1993) 20-25.
- Hiserodt, T.G. Hartman, C.T. Ho, R.T. Rosen, J. Chromatogr. A 740 (1996) 51-3.
- H. Tonnesen, J. karlsen, J. Chromatogr. A 259 (1983) 367-371.
- H. Khurana, J. Liq. Chromatogr. 11 (1988) 2296-2304.
- X.G. He, L.Z. Lin, L.Z. Lian, M. Lindenmaier, J. Chromatogr. A 818 (1998) 127-132.
- Prasad D. Rao CM. Indian J Pharm Sci 1995; 33:845.
- Chitra P. Sajithal GB. Chandra KG. Indian J Exp Biology 1998; 36:896.
- Jaswanth A. Akilandeswari LV. Manimaran S. Rukmani Indian J Pharm Sci 2001; 63:41.
- Rang HP. Text book of pharmacology, International Student edition, Churchill living stone 1995: 246.
- Rekka E. Kourounakis PN. J Pharm Pharmacol 1991; 43:486.
- Morton JJP. Melon HM. Archives Internationales de Pharmcodynamic et de Therapie 1972; 176:117.
- Suguna L. Siva Kumar P. Chandrakaran G. Indian J Exp Biology 1996; 34:1208-1211.
- Lee KH. J. Pharmaceutical Sciences 1968; 1238-1240.
- Ehrlich EH. Hunt TK Ibid 1969; 170:103-206.
- Dipasquale G. Meli A. J Pharm Pharmacolgy 1965; 17:379.
- Weossner JFT. Arch Biochem 1961; 93:440.
- Yeo JH. Lee KW. Kim HC. Lyuny K. Biology and Pharmaceutical Bulletin 2000; 23:1220-1223.
- Rao GV. Shiv Kuamr HG Parathasa RG. Indian J Pharamcology 1996; 28:249-253.
- Thomas CA. Rama Sharma GVS. Indian Drugs 1999;6:203.
- Duke JA. Bogen Schutz-Godwain M. Ducellier JD. Handbook of Medicinal herbs CRC press, London 2002.
- Thripathy KP. Ananda VijayaKumar PR. Rajasekaran A. Indian Drugs 2001; 38:426.
- Tenni R. J Biochem 1988; 37:169-177.
- Sunitha S. Nagaraj M. Varalakshmip Fitotherapia 2001; 72:516-523.
- RP-HPLC Method for Simultaneous Estimation of Calcipotriene and Betamethasone Dipropionte and Its Combined Dosage Form
Authors
1 NRI Institute of Pharmacy, Bhopal, IN
Source
Asian Journal of Research in Chemistry, Vol 4, No 4 (2011), Pagination: 602-606Abstract
This work is concerned with application of simple, accurate, precise and highly selective reverse phase high performance liquid chromatographic (RP-HPLC) method for simultaneous estimation of Calcipotriene and Betamethasone dipropionate in combined dosage form. Chromatographic separation was achieved isocratically at 25oC on Zorbax SB-300 C18 column (150 _ 4.6 mm) with a mobile phase composed of Methanol: 0.005M (NH4)2PO4 (pH 7.4)- Buffer in the ratio of 45:55 % v/v/v at flow rate of 1.0 ml/min. Detection is carried out using a UV detector at 264 nm. The retention time of Calcipotriene and Betamethasone dipropionate was found to be 7.99 min and 13.99 min. respectively. The method was found to be linear in the range of 0.8-1.4 _ppm with mean recovery of 101.16%+ 0.6 % for Calcipotriene and 100.29%+0.25 % for Betamethasone dipropionate. The correlation coefficients for all components are close to 1. The developed method was validated according to ICH guidelines and values of accuracy, precision and other statistical analysis were found to be in good accordance with the prescribed values. Thus the proposed method was successfully applied for simultaneous determination of Calcipotriene and Betamethasone dipropionate in routine analysis.
Keywords
Calcipotriene, Betamethasone Dipropionate, RP-HPLC.- Enhancement of Dissolution Profile of Poorly Water Soluble Drug Using Water Soluble Carriers
Authors
1 Assistant Professor, Dr. Rajendra Gode Institute of Pharmacy, Amravati 444602, Maharashtra Principal, Dr. Rajendra Gode Institute of Pharmacy, Amravati 444602, Maharashtra, IN
2 Assistant Professor, Government College of Pharmacy, Karad 415124, Maharashtra, IN
Source
Asian Journal of Pharmaceutical Research, Vol 12, No 2 (2022), Pagination: 137 - 142Abstract
Teneligliptin Hydrobromide is a long-acting, orally bioavailable, pyrolidone anti-diabetic activity with a solubility of 1.7mg/ml in water which also depends upon the pH and temperature of the solvent. So, Solid dispersion of drug with different polymers an attempt was made to improve dissolution of teneligliptin hydrobromide. The aim of this study was to prepare, characterize and compare solid dispersions of poorly water soluble anti diabetic drug by using PVP and HPMC for enhancing the dissolution rate of the drug. The solid dispersions were prepared by physical mixing method and kneading method at 1:1, 1:2 and 2:1 ratios of drug to polymer. The drug-excipient interaction study showed that the drug and polymers were compatible with each other. The formulations were evaluated for percent drug content, micromeritics and in-vitro dissolution studies. In the present study it was seen that there was an increase in in-vitro drug release for solid dispersion as compared to the pure drug taken alone. Based on the pattern of drug release, the kneading method showed more drug release as compared to physical mix method. In physical mix method, the rate of dissolution of teneligliptin hydrobromide was increased in teneligliptin and Polyvinylpyrrolidone (PVP) with the proportion of (1:2) when compared to the other formulations. In kneading method, the rate of dissolution of teneligliptin hydrobromide was increased in drug and Hydroxypropylmethylcellulose (HPMC) with the proportion of (1:2) when compared to the other formulations. Finally, solid dispersion containing HPMC, as a carrier, gave faster dissolution rates among all the formulations and was selected as the optimized formulation inthis study.
Keywords
Teneligliptin Hydrobromide, Antidiabetic, Dissolution enhancement, Solid Dispersion, HPMC, PVPReferences
- Habib MJ. Historical background of solid dispersions. Pharmaceutical solid dispersion technology, Lancaster: Technomic. 2001; 1-6.
- Patel CA, Patel PR, Sen JD, Patel JK. Enhancement of Solubility of Poorly Water Soluble Drug (Allopurinol) Through Solid Dispersion. Research J. Pharma. Dosage Forms and Tech. 2010; 2(2):156-163
- Ahuja N, Katare OM and Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. European Journal of Pharmaceutics and Biopharmaceutics. 2007; 65(1): 26- 38.
- Bhise SB and Rajkumar M. Effect of HPMC on solubility and dissolution of carbamazepine from III in simulated gastrointestinal fluids. Asian J Pharm. 2008; 38-42.
- Vasconcelos TF, Sarmento B and Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today. 2007; 12(23-24): 1068-1075.
- Laitinen R et al. Intra orally fast-dissolving particles of a poorly soluble drug: Preparation and invitro characterization. European Journal of Pharmaceutics and Biopharmaceutics. 2009; 71(2): 271- 281.
- Vippagunta SR et al. Factors affecting the formation of eutectic solid dispersions and their dissolution behaviour. J. Pharm. Sci. 2006; 96: 294-304.
- Patil, M., Jani, H., Khoja, S., Pirani, N., and Khoja, S. A Review on chemistry and pharmacological activity of metformin hydrochloride and teneligliptin hydrobromide hydrate in combined dosage form. Pharma Tutor. 2017; 5(3), 24-30.
- Reddy KM., Rao NB., K. Reddy RK. Study on Effect of Excipients in Enhancing the Solubility of Nateglinide by Solid Dispersions. Asian J. Pharm. Tech. 2(1): Jan.-Mar. 2012; Page 04-07.
- Chaulang G, Patil K, Ghodke D, Khan S, Yeole P. Preparation and characterization of solid dispersion tablet of furosemide with crospovidone. Research journal of pharmacy and technology. 2008;1(4):386-9.
- Bhalerao AV, Deshkar SS, Shirolkar SV, Gharge VG, Deshpande AD. Development and evaluation of clonazepam fast disintigrating tablets using superdisintigrates and solid dispersion technique. Research Journal of Pharmacy and Technology. 2009;2(2):375-7.
- Pradeep NS. A Review: Increasing Solubility of Poorly Soluble Drugs, by Solid Dispersion Technique. Research Journal of Pharmacy and Technology. 2011;4(12):1933-40.
- Sharma D, Soni M, Kumar S, Gupta GD. Solubility enhancement– eminent role in poorly soluble drugs. Research Journal of Pharmacy and Technology. 2009;2(2):220-4.
- Yadav AV, Yadav VB. Improvement of Physicochemical properties of Mesalamine with Hydrophilic Carriers by Solid Dispersion (kneading) method. Research Journal of Pharmacy and Technology. 2008;1(4):422-5.
- Rao TV, Vidyadhara S, Sambasivarao KR. Formulation and In- Vitro evaluation of Aceclofenac Controlled release tablets by wet granulation method and solid dispersion technique. Research Journal of Pharmacy and Technology. 2012;5(4):505-12.
- Bhise S, Chaulang G, Patel P , Bhosale A, Hardikar S. Superdisintegrants as solubilizing agent. Research Journal of Pharmacy and Technology. 2009;2(2):387-91.
- Eswaraiah MC, Jaya S. Enhancement of Dissolution Rate of Telmisartan by Solid Dispersion Technique. Research Journal of Pharmacy and Technology. 2020;13(5):2217-20.
- Mahore JG, Deshkar SS, Kumare PP. Solid Dispersion Technique for Solubility Improvement of Ketoconazole for Vaginal Delivery. Research Journal of Pharmacy and Technology. 2019;12(4):1649-54.
- Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS pharmscitech. 2006 Sep 1;7(3):E87.
- Malviya V, Ladhake V, Gajbiye K, Satao J, Tawar M. Design and Characterization of Phase Transition System of Zolmitriptan Hydrochloride for Nasal Drug Delivery System. International Journal of Pharmaceutical Sciences and Nanotechnology. 2020 May 31;13(3):4942-51.
- Malviya V, Thakur Y, Gudadhe SS, Tawar M. Formulation and evaluation of natural gum based fast dissolving tablet of Meclizine hydrochloride by using 3 factorial design 2. Asian Journal of Pharmacy and Pharmacology. 2020;6(2):94-100.
- Jung JY, Yoo SD, Lee SH, Kim KH, Yoon DS, Lee KH. Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. International journal of pharmaceutics. 1999 Oct 5;187(2):209-18.
- Shin SC, Kim J. Physicochemical characterization of solid dispersion of furosemide with TPGS. International journal of pharmaceutics. 2003 ;251(1-2):79-84.
- Nakkala B, Kishore SV, Gouda KH. Formulation and Evaluation of Simvastatin Solid Dispersions for Dissolution Rate Enhancement. Research J. Pharma. Dosage Forms and Tech. 2011; 3(4): 152-156.
- Jayarao RY, Deborah D, Ambedkar T, Manohar BS. Formulation and Evaluation of Fast Dissolving Oral Films of Perindopril. Res. J. Pharm. Dosage Form. and Tech. 6(2): 2014; 71-80
- Mewada A, Shah S, Tyagi CK. Enhancement of Solubility and Dissolution rate of Pravastatin using solid Dispersion. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(2):89-4.
- Sankar RK, Prasanthi NL, Manikiran SS, Rao RN. Effect of Solid Dispersion Technique on Improving the Solubility of Roxithromycin. Research J. Pharma. Dosage Forms and Tech. 2010; 2(2):184-188.
- B. Divya, Sabitha P ., Reddy R., Reddy KM, Rao NB. An Approach to Enhance Solubility of Gatifloxacin by Solid Dispersion Technique. Asian J. Res. Pharm. Sci. 2(2): 2012; 58-61.
- Tiwari G., Tiwari R., Srivastava B., Rai AK. Development and optimization of multi-unit solid dispersion systems of poorly water soluble drug. Research J. Pharm. and Tech. 1(4): 2008; 444-449
- Jain S., Pillai S., Mandloi RS., Namdev N., Birla N. Formulation and Evaluation of Fast Dissolving film of Labetalol Hydrochloride. Res. J. Pharmacognosy and Phytochem. 2021; 13(1):1-4.